Genzyme news from FierceBioResearcher
NewsScientists herald "breakthrough" on blindness
Activating the Robo4 protein in mice helped them to develop working blood vessels and ward off the kind of common physical damage that leads to blindness. And the work may point to new therapies for Read more...
Millipore in $1.6B makeover as life sciences supplier
Millipore is expanding on its reputation as a filtration supplier to scientific labs around the globe. Known for purified water and filters, Millipore has leveraged several buyouts to increase its Read more...
| Press ReleasesGenzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen Breakthrough, Potential Blockbuster Product for High Risk Cardiovascular Patients Genzyme and Isis Read more... PRESS RELEASE: FOVEA Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With GENZYME Corporation FOVEA Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With GENZYME Corporation PARIS, Nov. 27 -- FOVEA Pharmaceuticals SA. announced today that they have entered into a Read more... PRESS RELEASE: Genzyme Corporation Receives FDA Response Letter on Synvisc-One(TM) Approval in U.S. to be Delayed Genzyme Corporation Receives FDA Response Letter on Synvisc-One(TM) Approval in U.S. to be Delayed CAMBRIDGE, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that it has Read more... PRESS RELEASE: Genzyme Corporation's Epicel Wins Marketing Approval for Severe Burn Victims Genzyme Corporation's Epicel Wins Marketing Approval for Severe Burn Victims CAMBRIDGE, Mass., Oct. 29 -- Genzyme Corporation announced today that the U.S. Food and Drug Administration (FDA) has Read more... PRESS RELEASE: Bioenvision Shareholders Approve Acquisition by Genzyme Corporation Bioenvision Shareholders Approve Acquisition by Genzyme Corporation Genzyme Corporation and Bioenvision announced this afternoon that Bioenvision stockholders have voted to approve the acquisition Read more... |
Get more Genzyme coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight